SCHEMBL1142899

SCHEMBL1142899

CCCCCC/C=C\CCCCCC(C)OCCC

nearest known ligand 0.57

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
FAAH O00519 2/20 0.44
TRPV1 Q8NER1 1/20 0.44
ALDH1A1 P00352 1/20 0.44
CNR1 P21554 1/20 0.44
CNR2 P34972 1/20 0.44
LPAR1 Q92633 1/20 0.42
LPAR2 Q9HBW0 1/20 0.42
LPAR3 Q9UBY5 1/20 0.42
FFAR1 O14842 1/20 0.40
FFAR4 Q5NUL3 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1142291 1.00 FAAH (0.44) FAAHTRPV1ALDH1A1CNR1CNR2
SCHEMBL1142829 1.00 FAAH (0.44) FAAHTRPV1ALDH1A1CNR1CNR2
SCHEMBL1142378 0.96 LPAR2 (0.42) FAAHTRPV1ALDH1A1CNR1CNR2
SCHEMBL1142548 0.93 ALDH1A1 (0.47) FAAHTRPV1ALDH1A1CNR1CNR2
SCHEMBL1142603 0.93 ALDH1A1 (0.47) FAAHTRPV1ALDH1A1CNR1CNR2
SCHEMBL4018632 0.93 ALDH1A1 (0.51) FAAHTRPV1ALDH1A1CNR1CNR2
SCHEMBL1142329 0.93 ALDH1A1 (0.47) FAAHTRPV1ALDH1A1CNR1CNR2
SCHEMBL1142741 0.89 ALDH1A1 (0.44) FAAHTRPV1ALDH1A1CNR1CNR2
SCHEMBL17253408 0.88 OPRM1 (0.42) FAAHALDH1A1CNR1CNR2
SCHEMBL7777210 0.88 OPRM1 (0.42) FAAHALDH1A1CNR1CNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110035995-A1 BIOFUEL COMPOSITION AND MANUFACTURING PROCESS BUSCH RAINER 2011-02-17 US claimed
EP-2201156-A2 BIOFUEL COMPOSITION AND MANUFACTURING PROCESS Busch, Rainer (US) 2010-06-30 EP claimed
WO-2009035689-A2 BIOFUEL COMPOSITION AND MANUFACTURING PROCESS BUSCH RAINER (US) 2009-03-19 WO claimed
EP-2201156-B1 BIOFUEL COMPOSITION AND MANUFACTURING PROCESS BUSCH RAINER (US) 2013-10-02 EP disclosed
US-8444845-B2 Biofuel composition and manufacturing process BUSCH RAINER (US) 2013-05-21 US disclosed
US-20110035995-A1 BIOFUEL COMPOSITION AND MANUFACTURING PROCESS BUSCH RAINER 2011-02-17 US disclosed
EP-2201156-A2 BIOFUEL COMPOSITION AND MANUFACTURING PROCESS Busch, Rainer (US) 2010-06-30 EP disclosed
WO-2009035689-A2 BIOFUEL COMPOSITION AND MANUFACTURING PROCESS BUSCH RAINER (US) 2009-03-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110035995-A1 BIOFUEL COMPOSITION AND MANUFACTURING PROCESS FASN, SCD, ADH1A FAAH 163/4885TRPV1 2959/4885ALDH1A1 122/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.